Advertisement
Screener

EXAGEN INC. (XGN) ROI

EXAGEN INC. (XGN) ROI

  • 2026-06-30: ROI -53.98%.
  • 2026-03-31: ROI -54.06%.
  • 2025-12-31: ROI -49.44%.
  • 2025-09-30: ROI -46.35%.

Complete source-backed roi history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical ROI

DateROI
2026-06-30-53.98%
2026-03-31-54.06%
2025-12-31-49.44%
2025-09-30-46.35%
2025-06-30-38.58%
2025-03-31-56.71%
2024-12-31-50.75%
2024-09-30-51.11%
2024-06-30-45.76%
2024-03-31-48.98%
2023-12-31-56.15%
2023-09-30-69.15%
2023-06-30-68.50%
2023-03-31-68.63%
2022-12-31-66.34%
2021-12-31-23.89%

Annual ROI

DateROI
2025-12-31-49.44%
2024-12-31-50.75%
2023-12-31-56.15%
2022-12-31-66.34%
2021-12-31-23.89%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Freenome, Inc. (FRNM)United States$0.143B
BIODESIX INC (BDSX)United States$0.312B
SERA PROGNOSTICS, INC. (SERA)United States$0.062B-5.75
AMERICAN SHARED HOSPITAL SERVICES (AMS)United States$0.010B-5.64
Advanced Biomed Inc. (ADVB)$0.009B
Aclarion, Inc. (ACON)United States$0.008B
BioNexus Gene Lab Corp (BGLC)$0.004B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45